Related Experiment Video
Updated: Aug 1, 2026

09:41
A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery
Published on: May 20, 2016
12.7K
Automated deep learning pipeline for callosal angle quantification
Siavash Shirzadeh Barough1, Murat Bilgel2, Catalina Ventura1
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Fluids and Barriers of the CNS
|December 27, 2025
Summary
We developed an automated deep learning framework to measure the callosal angle (CA) for diagnosing normal pressure hydrocephalus (NPH). This tool offers a reliable and reproducible alternative to manual measurements, improving early NPH detection.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Normal pressure hydrocephalus (NPH) is an underdiagnosed neurodegenerative disorder.
- Manual analysis of imaging biomarkers like callosal angle (CA) is labor-intensive and subjective.
- Automated analysis is needed to improve NPH diagnosis.
Purpose of the Study:
- To develop a fully automated deep learning framework for measuring the callosal angle (CA) from T1 MPRAGE MRI scans.
- To provide a robust and reproducible method for CA measurement, aiding NPH diagnosis.
Main Methods:
- A deep learning framework integrating BrainSignsNET for landmark detection (AC, PC) and a UNet-based network for lateral ventricle segmentation.
- Input: 3D MRI scans preprocessed and reoriented.
- Output: Automated measurement of the callosal angle (CA).
Main Results:
- The framework achieved high concordance with manual CA measurements (r=0.98, p<0.001).
- Mean absolute error (MAE) was 3.26 degrees.
- Performance was independent of patient age, gender, and Evans Index (EI), indicating broad applicability.
Conclusions:
- The automated CA measurement framework is reliable and reproducible, surpassing manual methods and interobserver variability.
- This tool has significant potential for enhancing early NPH detection and diagnosis in research and clinical settings.

